{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:19:06Z","timestamp":1789676346906,"version":"4.0.1"},"reference-count":34,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Antimoniate therapy, in association with allopurinol, is one of the first-line treatments of canine leishmaniasis (CanL). This study evaluates the potential adverse effects associated with aNm in the treatment of CanL through both a retrospective analysis and a long-term prospective study also aimed to investigate its efficacy. The retrospective study reviewed records of 87 dogs with CanL with at least one follow-up available during or at the end of therapy with aNm (Glucantime\u00ae) at a dose of 50 mg\/kg administered subcutaneously twice a day in association with allopurinol. In total, 29.8% of dogs showed adverse effects during treatment as local reactions at the injection site (n = 6), severe systemic reaction to pain (originating from the inoculation site) with depression and anorexia (n = 4), systemic disease due to renal function worsening (n = 4), acute pancreatitis (n = 1), diarrhea (n = 5), vomiting (n = 3) and severe idiosyncratic skin reactions (n = 3). Of these dogs, 13 (14.9%) required treatment suspension. The prospective study included 16 dogs, selected among the LeishVet stages II and III CKD IRIS stage 1 (International Renal Interest Society staging of canine Chronic Kidney Disease) and treated with the same aNm plus allopurinol protocol as in the retrospective study and observed for 360 days; 2 dogs were excluded for severe reactions at the injection site. Mild and transient adverse events were reported in the other 4 dogs. The criteria used to evaluate the efficacy of treatment with aNm were as follows: a reduction in the clinical score and improvement and\/or normalization of laboratory parameters, negativization of PCR on the bone marrow samples and disease-free interval time. The proportion of reduction in the clinical score reached 91.9% at D180. No animals showed clinical laboratory relapse during the whole study duration and interestingly, the PCR results showed complete negativity between D0 and D60 in 78.5% of animals. Veterinarians must be vigilant regarding the potentially serious adverse effects associated with aNm and promptly stop drug administration if unexpected clinical manifestations occur. On the other hand, they should not discard its use for CanL treatment since it is confirmed that aNm in association with allopurinol is highly effective in controlling CanL.<\/jats:p>","DOI":"10.3390\/ani14152244","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T15:26:53Z","timestamp":1722526013000},"page":"2244","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment of Canine Leishmaniasis with Meglumine Antimoniate: A Clinical Study of Tolerability and Efficacy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7214-0932","authenticated-orcid":false,"given":"Serena","family":"Digiaro","sequence":"first","affiliation":[{"name":"Department DiMePre-J, Veterinary Section, University of Bari \u201cAldo Moro\u201d, Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2722-4835","authenticated-orcid":false,"given":"Alessandra","family":"Recchia","sequence":"additional","affiliation":[{"name":"Department DiMePre-J, Veterinary Section, University of Bari \u201cAldo Moro\u201d, Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-9156","authenticated-orcid":false,"given":"Antonella","family":"Colella","sequence":"additional","affiliation":[{"name":"Department DiMePre-J, Veterinary Section, University of Bari \u201cAldo Moro\u201d, Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cucciniello","sequence":"additional","affiliation":[{"name":"Department DiMePre-J, Veterinary Section, University of Bari \u201cAldo Moro\u201d, Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Greco","sequence":"additional","affiliation":[{"name":"Department DiMePre-J, Veterinary Section, University of Bari \u201cAldo Moro\u201d, Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0108-6822","authenticated-orcid":false,"given":"Dora","family":"Buonfrate","sequence":"additional","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar, 37024 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8820-1453","authenticated-orcid":false,"given":"Paola","family":"Paradies","sequence":"additional","affiliation":[{"name":"Department DiMePre-J, Veterinary Section, University of Bari \u201cAldo Moro\u201d, Strada Provinciale Casamassima km3, Valenzano, 70010 Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Morales-Yuste, M., Mart\u00edn-S\u00e1nchez, J., and Corpas-Lopez, V. (2022). Canine Leishmaniasis: Update on Epidemiology, Diagnosis, Treatment, and Prevention. Vet. Sci., 9.","DOI":"10.3390\/vetsci9080387"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cyto.2018.08.019","article-title":"A Leishmania Hypothetical Protein-Containing Liposome-Based Formulation Is Highly Immunogenic and Induces Protection against Visceral Leishmaniasis","volume":"111","author":"Ribeiro","year":"2018","journal-title":"Cytokine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.tvjl.2014.09.002","article-title":"An Update on the Diagnosis and Treatment of Canine Leishmaniosis Caused by Leishmania Infantum (Syn. L.\u2009Chagasi)","volume":"202","author":"Noli","year":"2014","journal-title":"Vet. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniosis","volume":"106","author":"Baneth","year":"2002","journal-title":"Vet. Parasitol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.tvjl.2009.09.011","article-title":"Clinical and Laboratory Monitoring of Dogs Naturally Infected by Leishmania infantum","volume":"186","author":"Paradies","year":"2010","journal-title":"Vet. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3855\/jidc.10050","article-title":"Tolerability and Pharmacokinetics of Two Antimony Products after Subcutaneous Administration in Dogs","volume":"12","author":"Rambaldi","year":"2018","journal-title":"J. Infect. Dev. Ctries"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Iarussi, F., Paradies, P., Foglia Manzillo, V., Gizzarelli, M., Caratozzolo, M.F., Navarro, C., Greco, B., Rubino, G.T.R., Oliva, G., and Sasanelli, M. (2020). Comparison of Two Dosing Regimens of Miltefosine, Both in Combination with Allopurinol, on Clinical and Parasitological Findings of Dogs with Leishmaniosis: A Pilot Study. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.577395"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s13071-015-0896-0","article-title":"Long-Term Follow-up of Dogs with Leishmaniosis Treated with Meglumine Antimoniate plus Allopurinol versus Miltefosine plus Allopurinol","volume":"8","author":"Manna","year":"2015","journal-title":"Parasites Vectors"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tvjl.2010.05.025","article-title":"Long Term Follow-up of Dogs Diagnosed with Leishmaniosis (Clinical Stage II) and Treated with Meglumine Antimoniate and Allopurinol","volume":"188","author":"Torres","year":"2011","journal-title":"Vet. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2460\/javma.236.11.1192","article-title":"Guidelines for Treatment of Leishmaniasis in Dogs","volume":"236","author":"Oliva","year":"2010","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.rvsc.2012.01.005","article-title":"Monitoring the Reverse to Normal of Clinico-Pathological Findings and the Disease Free Interval Time Using Four Different Treatment Protocols for Canine Leishmaniosis in an Endemic Area","volume":"93","author":"Paradies","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.rvsc.2019.08.026","article-title":"Short Term Impacts of Meglumine Antimoniate Treatment on Kidney Function in Dogs with Clinical Leishmaniosis","volume":"126","year":"2019","journal-title":"Res. Vet. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tvjl.2013.10.007","article-title":"Paraoxonase Activity as a Tool for Clinical Monitoring of Dogs Treated for Canine Leishmaniasis","volume":"199","author":"Rossi","year":"2014","journal-title":"Vet. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.rvsc.2016.09.003","article-title":"Serum C-Reactive Protein and Ferritin Concentrations in Dogs Undergoing Leishmaniosis Treatment","volume":"109","author":"Tecles","year":"2016","journal-title":"Res. Vet. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Santos, M.F., Alexandre-Pires, G., Pereira, M.A., Marques, C.S., Gomes, J., Correia, J., Duarte, A., Gomes, L., Rodrigues, A.V., and Basso, A. (2019). Meglumine Antimoniate and Miltefosine Combined With Allopurinol Sustain Pro-Inflammatory Immune Environments During Canine Leishmaniosis Treatment. Front. Vet. Sci., 6.","DOI":"10.3389\/fvets.2019.00362"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/jpp\/rgab081","article-title":"Improved Efficacy of Meglumine Antimoniate Incorporated in Anionic Liposomes against Leishmania Infantum Infecting Canine Macrophages","volume":"74","author":"Ortega","year":"2022","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00436-009-1375-3","article-title":"Comparative Study on the Short Term Efficacy and Adverse Effects of Miltefosine and Meglumine Antimoniate in Dogs with Natural Leishmaniosis","volume":"105","author":"Mateo","year":"2009","journal-title":"Parasitol. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.rvsc.2006.10.008","article-title":"Evaluation of Renal and Hepatic Functions in Dogs Naturally Infected by Visceral Leishmaniasis Submitted to Treatment with Meglumine Antimoniate","volume":"83","author":"Lopes","year":"2007","journal-title":"Res. Vet. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1177\/0192623309344088","article-title":"Administration of Miltefosine and Meglumine Antimoniate in Healthy Dogs: Clinicopathological Evaluation of the Impact on the Kidneys","volume":"37","author":"Bianciardi","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"904","DOI":"10.14202\/vetworld.2016.904-908","article-title":"Proteinuria Reduction after Treatment with Miltefosine and Allopurinol in Dogs Naturally Infected with Leishmaniasis","volume":"9","author":"Proverbio","year":"2016","journal-title":"Vet. World."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tvjl.2013.04.001","article-title":"Prognosis and Monitoring of Leishmaniasis in Dogs: A Working Group Report","volume":"198","author":"Roura","year":"2013","journal-title":"Vet. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-3305-4-86","article-title":"LeishVet Guidelines for the Practical Management of Canine Leishmaniosis","volume":"4","author":"Koutinas","year":"2011","journal-title":"Parasites Vectors"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-3164.2009.00824.x","article-title":"Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis","volume":"20","author":"Oliva","year":"2009","journal-title":"Vet. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4269\/ajtmh.2005.73.82","article-title":"Evaluation of Lymph Node and Bone Marrow Cytology in the Diagnosis of Canine Leishmaniasis (Leishmania infantum) in Symptomatic and Asymptomatic Dogs","volume":"73","author":"Saridomichelakis","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_25","unstructured":"Gradoni, L., and Gramiccia, M. (2008). \u201cLeishmaniosis\u201d in OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (Mammals, Birds and Bees), Office International des Epizooties. [6th ed.]."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-6851(92)90208-2","article-title":"Sequence Analysis of Small Subunit Ribosomal RNA Genes and Its Use for Detection and Identification of Leishmania Parasites","volume":"51","author":"Schoone","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Pereira, M.A., Santos, R., Oliveira, R., Costa, L., Prata, A., Gon\u00e7alves, V., Roquette, M., Vala, H., and Santos-Gomes, G. (2020). Prognostic Factors and Life Expectancy in Canine Leishmaniosis. Vet. Sci., 7.","DOI":"10.3390\/vetsci7030128"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4314\/eamj.v78i11.8952","article-title":"Electrocardiographic Findings in Ethiopians on Pentavalent Antimony Therapy for Visceral Leishmaniasis","volume":"78","author":"Berhe","year":"2001","journal-title":"East. Afr. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.actatropica.2011.02.007","article-title":"Systematic Review of the Adverse Effects of Cutaneous Leishmaniasis Treatment in the New World","volume":"118","author":"Oliveira","year":"2011","journal-title":"Acta Trop."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.vetpar.2014.03.033","article-title":"Prospective Evaluation of Serum Pancreatic Lipase Immunoreactivity and Troponin I Concentrations in Leishmania Infantum-Infected Dogs Treated with Meglumine Antimonate","volume":"203","author":"Xenoulis","year":"2014","journal-title":"Vet. Parasitol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11259-005-0059-4","article-title":"Pancreatitis Associated with N-Methyl-Glucamine Therapy in a Dog with Leishmaniasis","volume":"29","author":"Aste","year":"2005","journal-title":"Vet. Res. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1939-1676.2006.tb02850.x","article-title":"Effects of Allopurinol Treatment on the Progression of Chronic Nephritis in Canine Leishmaniosis (Leishmania Infantum)","volume":"20","author":"Plevraki","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.rvsc.2018.05.014","article-title":"Use of Urinary \u03b3-Glutamyl Transferase (GGT) to Monitor the Pattern of Proteinuria in Dogs with Leishmaniasis Treated with N-Methylglucamine Antimoniate","volume":"119","author":"Paltrinieri","year":"2018","journal-title":"Res. Vet. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ol\u00edas-Molero, A., Corral, M.J., Jim\u00e9nez-Ant\u00f3n, M.D., and Alunda, J.M. (2019). Early antibody response and clinical outcome in experimental canine leishmaniasis. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-55087-w"}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/15\/2244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:28:31Z","timestamp":1760110111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/15\/2244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":34,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ani14152244"],"URL":"https:\/\/doi.org\/10.3390\/ani14152244","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}